
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Supplements and Featured Publications
almost 25 years ago
Participating Facultyalmost 25 years ago
Introductionalmost 25 years ago
State of the Art in Cholesterol Management: Targeting Multiple Pathwaysalmost 25 years ago
Panel Discussionalmost 25 years ago
Continuing Medical Education Quiz

